Table 3.

Infections recorded for Indigenous and non-Indigenous adults during the 5 years prior to the final BSI presentation*

	Indigenous n=431 (%)	Non-Indigenous (n=52)	p Value
Any	296 (68.7)	18 (34.6)	<0.001
BSI	105 (24.4)	4 (7.7)	0.007
Respiratory tract	179 (41.5)	3 (5.8)	<0.001
Pneumonia	164 (38.1)	4 (7.7)	<0.001
>3 Episodes	32 (7.4)	0 (0.0)	0.04
Exacerbation BE	13 (6.0)	0 (0.0)	0.20
Skin/soft tissue infections	154 (35.7)	7 (13.5)	0.001
Abscess	88 (20.5)	0 (0.0)	<0.001
Cellulitis	47 (10.9)	7 (13.7)	0.55
Wound infection	42 (9.7)	0 (0.0)	0.02
Pyelonephritis	77 (17.9)	4 (7.7)	0.06
Bone/joint	11 (2.6)	0 (0.0)	0.24
Enteritis	21 (4.9)	1 (1.9)	0.33
Scabies	14 (3.3)	0 (0.0)	0.19
Other	6 (1.4)	0 (0.0)	0.39

*Excluding haemodialysis patients (n=83 indigenous, 3 non-indigenous), patients with bronchiectasis (n=27 Indigenous, 0 non-indigenous) and those residing outside the Alice Springs urban and rural districts for whom data were not available (Indigenous, 18; non-Indigenous, 0).

BSI, bloodstream infections; BE, bronchiectasis.